StockNews.com began coverage on shares of Aethlon Medical (NASDAQ:AEMD – Free Report) in a research report sent to investors on Friday. The brokerage issued a sell rating on the medical equipment provider’s stock.
Aethlon Medical Trading Up 6.0 %
AEMD opened at $0.43 on Friday. The stock has a 50-day moving average price of $0.40 and a 200-day moving average price of $0.51. Aethlon Medical has a 12-month low of $0.24 and a 12-month high of $2.35.
Aethlon Medical (NASDAQ:AEMD – Get Free Report) last issued its earnings results on Wednesday, August 14th. The medical equipment provider reported ($0.34) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.44) by $0.10. During the same period in the previous year, the business posted ($1.30) earnings per share. On average, research analysts anticipate that Aethlon Medical will post -1.1 earnings per share for the current fiscal year.
Aethlon Medical Company Profile
Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.
Further Reading
- Five stocks we like better than Aethlon Medical
- Stock Dividend Cuts Happen Are You Ready?
- 2 Chip Stocks Benefitting from OpenAI’s Chip Strategy Expansion
- When to Sell a Stock for Profit or Loss
- Monday.com’s Manic Price Pullback Is a Signal to Buy
- How to Calculate Inflation Rate
- 3 “Made in America” Stocks to Benefit From the Trump Presidency
Receive News & Ratings for Aethlon Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aethlon Medical and related companies with MarketBeat.com's FREE daily email newsletter.
